Glucagon-like peptide-1 (GLP-1) is a gut-derived incretin hormone that induces weight loss and insulin sensitivity by improving insulin synthesis and release, reduces glucagon secretion and hepatic gluconeogenesis, reduces steatosis, and affects lipid metabolism by decreasing lipogenesis and increasing oxidation to metabolize fatty acids [48]. This evidence concerns the gene INS and steatosis.